Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boston Scientific
BSX
|
+$240M |
| 2 |
eBay
EBAY
|
+$231M |
| 3 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$216M |
| 4 |
Ameren
AEE
|
+$196M |
| 5 |
Kohl's
KSS
|
+$182M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$552M |
| 2 |
Micron Technology
MU
|
+$425M |
| 3 |
Visa
V
|
+$225M |
| 4 |
Marathon Petroleum
MPC
|
+$225M |
| 5 |
ESRX
Express Scripts Holding Company
ESRX
|
+$218M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 13.6% |
| 2 | Healthcare | 12.02% |
| 3 | Technology | 11.62% |
| 4 | Industrials | 11.19% |
| 5 | Consumer Discretionary | 10.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1401
Flowserve
FLS
$9.71B
| $9.01M | 0.01% |
+207,869
| New | +$9.05M |
|
1402
Argan
AGX
$8B
| $9M | 0.01% |
209,623
+80,203
| +62% | +$3.38M |
|
1403
First Merchants
FRME
$2.68B
| $8.99M | 0.01% |
215,500
+203,005
| +1,625% | +$8.68M |
|
1404
Crocs
CROX
$6.14B
| $8.95M | 0.01% |
550,704
-1,396,654
| -72% | -$19.4M |
|
1405
Unisys
UIS
$209M
| $8.93M | 0.01% |
830,903
+568,584
| +217% | +$5.72M |
|
|
ACGN
1406
DELISTED
Aceragen Inc
ACGN
| $8.92M | 0.01% |
35,687
+7,318
| +26% | +$2.01M |
|
|
CELG
1407
CALL
DELISTED
Celgene Corp
CELG
| $8.92M | 0.01% |
+100,000
| New | +$9.6M |
|
|
CELG
1408
PUT
DELISTED
Celgene Corp
CELG
| $8.92M | 0.01% |
+100,000
| New | +$9.6M |
|
1409
Benchmark Electronics
BHE
$2.87B
| $8.91M | 0.01% |
298,589
+258,856
| +651% | +$7.77M |
|
|
PDCE
1410
DELISTED
PDC Energy, Inc.
PDCE
| $8.91M | 0.01% |
181,768
+122,300
| +206% | +$6.44M |
|
|
REGI
1411
DELISTED
Renewable Energy Group, Inc.
REGI
| $8.9M | 0.01% |
695,642
+682,058
| +5,021% | +$7.65M |
|
|
DERM
1412
DELISTED
Dermira, Inc.
DERM
| $8.88M | 0.01% |
1,111,031
+209,050
| +23% | +$4.55M |
|
1413
Quad
QUAD
$536M
| $8.86M | 0.01% |
349,338
+175,663
| +101% | +$4.28M |
|
|
MYOK
1414
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $8.85M | 0.01% |
181,325
-309,425
| -63% | -$16.1M |
|
1415
Children's Place
PLCE
$54.3M
| $8.81M | 0.01% |
65,128
+57,400
| +743% | +$8.34M |
|
1416
ASE Group
ASX
$77.3B
| $8.8M | 0.01% |
1,211,970
+281,781
| +30% | +$1.98M |
|
1417
CALL
Freeport-McMoran
FCX
$90B
| $8.79M | 0.01% |
500,000
-200,000
| -29% | -$3.75M |
|
|
NRE
1418
DELISTED
NorthStar Realty Europe Corp.
NRE
| $8.77M | 0.01% |
673,821
-53,917
| -7% | -$634K |
|
|
HTBK
1419
DELISTED
Heritage Commerce
HTBK
| $8.71M | 0.01% |
528,473
-85,016
| -14% | -$1.38M |
|
1420
PUT
Intercontinental Exchange
ICE
$85.6B
| $8.7M | 0.01% |
+120,000
| New | +$8.77M |
|
|
LPNT
1421
DELISTED
LifePoint Health, Inc.
LPNT
| $8.69M | 0.01% |
184,967
-762,612
| -80% | -$36.7M |
|
1422
Zimmer Biomet
ZBH
$18.2B
| $8.65M | 0.01% |
81,750
-390,214
| -83% | -$45.3M |
|
1423
PUT
T. Rowe Price
TROW
$23.9B
| $8.64M | 0.01% |
+80,000
| New | +$8.91M |
|
1424
St. Joe Company
JOE
$3.54B
| $8.63M | 0.01% |
458,029
-674,212
| -60% | -$12.5M |
|
1425
Iovance Biotherapeutics
IOVA
$1.82B
| $8.63M | 0.01% |
510,364
-139,287
| -21% | -$2.11M |
|
Similar funds
Millennium Management's Q1 2018 Portfolio in Review
As of Q1 2018, Millennium Management held 4,417 positions worth $74.9B, up 3.4% from $72.5B the previous quarter. Its ten largest holdings account for 6.3% of the portfolio.
Millennium Management deployed $3.3B of net new capital in Q1 2018, opening 664 new positions and adding to 1,467 existing holdings. Its largest new stake was Tiffany & Co.: 1,078,847 shares worth $105M.
By sector, the portfolio is most concentrated in Financials at 14% of assets, down from 14% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $552M trimmed.
- Millennium Management's largest Q1 2018 buy was Tiffany & Co.: 1,078,847 shares worth $105M.
- Millennium Management added most to Boston Scientific in Q1 2018, an estimated $240M increase.
- Millennium Management's biggest Q1 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $552M.
- Millennium Management fully exited Equinix in Q1 2018, selling an estimated $152M.
- Millennium Management's ten largest holdings make up 6.3% of its $74.9B portfolio in Q1 2018.
- Millennium Management opened 664 new positions and closed 833 in Q1 2018.
- Millennium Management's portfolio value rose 3.4% quarter-over-quarter to $74.9B.
Based on Millennium Management's 13F filing for Q1 2018, filed 15 May 2018.